Bioethics Blogs

PRIM&R’s Comments in Response to OHRP’s and FDA’s Draft Guidance on IRB Meeting Minutes

PRIM&R submitted comments to the Department of Health and Human Services’ (DHHS) Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) in response to their jointly released draft guidance on meeting minutes for institutional review boards (IRBs) who oversee human subjects research under the FDA and/or DHHS regulations.

The post PRIM&R’s Comments in Response to OHRP’s and FDA’s Draft Guidance on IRB Meeting Minutes appeared first on Ampersand.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.